Grifols is a leading global healthcare company that develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients around the world to lead more productive lives.
Since our founding in 1909, we have applied our ever-growing mastery of plasma, life sciences ethical leadership and industry-leading quality and safety standards to contribute to a healthier and more sustainable society.
